Literature DB >> 23376686

Deletion of macrophage migration inhibitory factor worsens stroke outcome in female mice.

L Christine Turtzo1, Jun Li, Rebecca Persky, Sharon Benashski, Gillian Weston, Richard Bucala, Venugopal Reddy Venna, Louise D McCullough.   

Abstract

Sex is an important factor in the response to ischemic insults in both the laboratory and the clinic. Inflammation and cell death are points where sex-specific pathways diverge in stroke, and serum estrogen level status affect the response to inflammation. The cytokine macrophage migration inhibitory factor (MIF) is detrimental in experimental stroke models in male animals. However MIF is known to have sex-specific actions on inflammation and wound healing. The role of MIF in the ischemic female brain has not been evaluated. A transient middle cerebral artery occlusion (MCAO/90min) model was used to induce stroke in male, intact female, and ovariectomized female wildtype (WT) and MIF knockout (KO) mice. Infarct size was quantified 72h after stroke. Protein and cytokine levels were assessed post stroke. Female MIF KO mice had significantly larger strokes compared to WT females (mean hemispheric infarct±SEM: 63%±2% versus 29%±3%; n=8; p<0.05). Ovariectomized female MIF KO mice also had larger infarcts than ovariectomized WT littermates (70%±3% versus 47%±4%; n=11; p<0.05). In males, however, infarct size was equivalent between MIF KO and WT mice (63%±2% versus 67%±3%; n=9; p=0.25). There were no significant differences in cytokine levels at 6h post-infarct between mice of either genotype in brain. MIF KO females displayed more microglial activation (ionized calcium binding adaptor molecule 1 (Iba1) immunofluorescence) after stroke than did WT mice or MIF KO males. The larger infarcts in MIF KO females were associated with an early increase in mitochondrial localization of Jun activation domain-binding protein 1 (JAB1). Loss of MIF exacerbated injury in the female brain after experimental stroke, which was independent of changes in pro-inflammatory cytokine levels. This response is sex-specific, and is in part independent of physiological serum levels of estrogen.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23376686      PMCID: PMC3628925          DOI: 10.1016/j.nbd.2013.01.016

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  65 in total

1.  Estrogen receptor antagonist ICI182,780 exacerbates ischemic injury in female mouse.

Authors:  M Sawada; N J Alkayed; S Goto; B J Crain; R J Traystman; A Shaivitz; R J Nelson; P D Hurn
Journal:  J Cereb Blood Flow Metab       Date:  2000-01       Impact factor: 6.200

2.  Null mutation in macrophage migration inhibitory factor prevents muscle cell loss and fibrosis in partial bladder outlet obstruction.

Authors:  John A Taylor; Qing Zhu; Brian Irwin; Yazeed Maghaydah; John Tsimikas; Carol Pilbeam; Lin Leng; Richard Bucala; George A Kuchel
Journal:  Am J Physiol Renal Physiol       Date:  2006-07-11

3.  Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IkappaBalpha.

Authors:  J M Daun; J G Cannon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-09       Impact factor: 3.619

4.  Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis.

Authors:  Anke Burger-Kentischer; Heike Goebel; Rüdiger Seiler; Gustav Fraedrich; Hans E Schaefer; Stefanie Dimmeler; Robert Kleemann; Jürgen Bernhagen; Christian Ihling
Journal:  Circulation       Date:  2002-04-02       Impact factor: 29.690

5.  Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1.

Authors:  R Kleemann; A Hausser; G Geiger; R Mischke; A Burger-Kentischer; O Flieger; F J Johannes; T Roger; T Calandra; A Kapurniotu; M Grell; D Finkelmeier; H Brunner; J Bernhagen
Journal:  Nature       Date:  2000-11-09       Impact factor: 49.962

6.  Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke.

Authors:  Ana R Inácio; Karsten Ruscher; Lin Leng; Richard Bucala; Tomas Deierborg
Journal:  J Cereb Blood Flow Metab       Date:  2010-11-10       Impact factor: 6.200

7.  Chronic behavioral testing after focal ischemia in the mouse: functional recovery and the effects of gender.

Authors:  Xiaoling Li; Kathleen K Blizzard; Zhiyuan Zeng; A Courtney DeVries; Patricia D Hurn; Louise D McCullough
Journal:  Exp Neurol       Date:  2004-05       Impact factor: 5.330

8.  Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia.

Authors:  Louise McCullough; Liejun Wu; Norman Haughey; Xibin Liang; Tracey Hand; Qian Wang; Richard M Breyer; Katrin Andreasson
Journal:  J Neurosci       Date:  2004-01-07       Impact factor: 6.167

Review 9.  Sex, stroke, and inflammation: the potential for estrogen-mediated immunoprotection in stroke.

Authors:  Rodney M Ritzel; Lori A Capozzi; Louise D McCullough
Journal:  Horm Behav       Date:  2012-04-24       Impact factor: 3.587

10.  Brain miffed by macrophage migration inhibitory factor.

Authors:  Nic E Savaskan; Günter Fingerle-Rowson; Michael Buchfelder; Ilker Y Eyüpoglu
Journal:  Int J Cell Biol       Date:  2012-09-03
View more
  20 in total

1.  A novel HLA-DRα1-MOG-35-55 construct treats experimental stroke.

Authors:  Gil Benedek; Wenbin Zhu; Nicole Libal; Amanda Casper; Xiaolin Yu; Roberto Meza-Romero; Arthur A Vandenbark; Nabil J Alkayed; Halina Offner
Journal:  Metab Brain Dis       Date:  2014-03       Impact factor: 3.584

2.  Macrophage Migration Inhibitory Factor Levels Correlate with Stroke Recurrence in Patients with Ischemic Stroke.

Authors:  Guangjie Wang; Chuanbin Li; Yashou Liu; Lei Xia
Journal:  Neurotox Res       Date:  2018-12-01       Impact factor: 3.911

Review 3.  The emerging roles of Jab1/CSN5 in cancer.

Authors:  Lin Wang; Jun-Nian Zheng; Dong-Sheng Pei
Journal:  Med Oncol       Date:  2016-07-13       Impact factor: 3.064

4.  Sex Differences in the Cerebral Collateral Circulation.

Authors:  James E Faber; Scott M Moore; Jennifer L Lucitti; Amir Aghajanian; Hua Zhang
Journal:  Transl Stroke Res       Date:  2016-11-14       Impact factor: 6.829

Review 5.  Partial MHC class II constructs as novel immunomodulatory therapy for stroke.

Authors:  Gil Benedek; Arthur A Vandenbark; Nabil J Alkayed; Halina Offner
Journal:  Neurochem Int       Date:  2016-10-31       Impact factor: 3.921

6.  The Association Between Serum Macrophage Migration Inhibitory Factor and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage.

Authors:  Xiaobo Yang; Jianhua Peng; Jinwei Pang; Weifeng Wan; Chuanhong Zhong; Tangming Peng; Kunyang Bao; Yong Jiang
Journal:  Neurotox Res       Date:  2019-07-02       Impact factor: 3.911

7.  Neuroprotective Effect of Macrophage Migration Inhibitory Factor (MIF) in a Mouse Model of Ischemic Stroke.

Authors:  Ji Ae Kim; Ye Young Kim; Seung Hak Lee; Chul Jung; Mi Hee Kim; Dae Yul Kim
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

8.  Ginkgo biloba Extract Prevents Female Mice from Ischemic Brain Damage and the Mechanism Is Independent of the HO1/Wnt Pathway.

Authors:  Jatin Tulsulkar; Bryan Glueck; Terry D Hinds; Zahoor A Shah
Journal:  Transl Stroke Res       Date:  2015-11-17       Impact factor: 6.829

9.  Inhibition of glycogen synthase kinase-3β enhances cognitive recovery after stroke: the role of TAK1.

Authors:  Venugopal Reddy Venna; Sharon E Benashski; Anjali Chauhan; Louise D McCullough
Journal:  Learn Mem       Date:  2015-06-15       Impact factor: 2.460

10.  Behavioural and neurobiological consequences of macrophage migration inhibitory factor gene deletion in mice.

Authors:  Cecilie Bay-Richter; Shorena Janelidze; Analise Sauro; Richard Bucala; Jack Lipton; Tomas Deierborg; Lena Brundin
Journal:  J Neuroinflammation       Date:  2015-09-04       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.